GSK Investigational Site is a clinical research site located in Northridge, California, United States 91328.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 31 clinical trials.
Therapeutic areas: Neoplasms, Breast, Gastroparesis, Migraine Disorders.
Sponsors: GlaxoSmithKline, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), XenoPort, Inc..
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 31 clinical trials on record. Their work covers Neoplasms, Breast, Gastroparesis, Migraine Disorders.
Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.